Previous 10 | Next 10 |
2023-08-03 17:41:02 ET IGM Biosciences press release ( NASDAQ: IGMS ): Q2 GAAP EPS of -$1.43 beats by $0.01 . Revenue of $0.45M (+21.6% Y/Y) misses by $0.34M . For further details see: IGM Biosciences GAAP EPS of -$1.43 beats by $0.01, revenue of $0.45M m...
– Continued progress in clinical development across portfolio – – Public equity offering and concurrent private placement with gross proceeds of $120.0 million – MOUNTAIN VIEW, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS)...
2023-07-16 09:06:49 ET Summary IGM Biosciences, developing IgM antibodies for various diseases, sees Q1 2023 cash decrease, but collaboration revenues rise. Imvotamab trial results disappoint; focus shifts to combination therapies, while IGM-8444, IGM-7354, IGM-2644 show potential...
2023-07-13 08:30:00 ET Summary June 2023 saw significant insider purchases in Lucid Group, Diversified Healthcare Trust, Akoya Biosciences, and Axon Enterprise. The Public Investment Fund bought $1.8 billion worth of shares in Lucid Group, increasing its ownership to 74.95%. Diver...
MOUNTAIN VIEW, Calif., July 03, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ: IGMS) today announced the closing of its previously announced upsized underwritten public offering of 1,597,827 shares of its voting common stock and 9,000,000 shares of its non-voting common stock and includi...
2023-06-22 10:02:12 ET Gainers: TRxADE HEALTH ( MEDS ) +39% . Talaris Therapeutics ( TALS ) +25% . IGM Biosciences ( IGMS ) +11% . Predictive Oncology ( POAI ) +4% . Zymeworks ( ZYME ) +3% . Losers: Innovative Eyewear...
2023-06-22 08:28:06 ET IGM Biosciences ( NASDAQ: IGMS ) has announced the pricing of its upsized underwritten public offering of 3.29M shares of its voting common stock and 7.31M shares of its non-voting common stock, in each case at a price to the public of $8/share. ...
MOUNTAIN VIEW, Calif., June 22, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ: IGMS) today announced the pricing of its upsized underwritten public offering of 3,285,327 shares of its voting common stock and 7,312,500 shares of its non-voting common stock, in each case at a price to the ...
2023-06-21 17:35:02 ET IGM Biosciences ( NASDAQ: IGMS ) said Wednesday that it intends to offer and sell $100 million of its common stock in an underwritten public offering. Underwriters have a 30-day option to purchase up to an additional 15% of the shares being offered...
MOUNTAIN VIEW, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ: IGMS) today announced that it intends to offer and sell an aggregate of $100.0 million of shares of its common stock and, in lieu of common stock to certain investors that so choose, non-voting common stock, i...
News, Short Squeeze, Breakout and More Instantly...
2024-05-31 20:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-24 12:15:03 ET RBC Capital analyst issues UNDERPERFORM recommendation for IGMS on May 24, 2024 10:00AM ET. The previous analyst recommendation was Underperform. IGMS was trading at $10.01 at issue of the analyst recommendation. The overall analyst consensus : BUY...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 33.8% to $0.0788 on volume of 1,221,538,672 shares Akoustis Technologies Inc. (AKTS) rose 128.8% to $0.3151 on volume of 536,119,838 shares Crown Electrokinetics Corp. (CRKN) rose 3.1% t...